Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.
Related Posts
General Motors is set to report earnings before the bell. Here’s what Wall Street expects
While investors will be watching GM’s quarterly results, they will also be focused on its guidance for 2025 and any changes under the Trump administration.
AMD announces $6 billion buyback; shares climb 6%
The authorization is in addition to $4 billion in existing approved share repurchases, the company said.
Trump signals U.S. and U.K. could reach ‘real trade deal’ without tariffs
U.S. President Donald Trump signaled the U.K. could broker a “real trade deal” and escape tariffs.